MONARCH PHARMACEUTICALS, INC. – Trademark Portfolio

Entity Type: 03

MONARCH PHARMACEUTICALS, INC. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MENEST and PROCTOCORT. The owner is based in BRISTOL, TN.

355 BEECHAM STREET

BRISTOL, TN 37620

16 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MONARCH PHARMACEUTICALS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (15 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does MONARCH PHARMACEUTICALS, INC. have?

MONARCH PHARMACEUTICALS, INC. has 16 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 11 cancelled.

What trademark classes does MONARCH PHARMACEUTICALS, INC. file in?

MONARCH PHARMACEUTICALS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are MONARCH PHARMACEUTICALS, INC.'s most well-known trademarks?

MONARCH PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as MENEST and PROCTOCORT. These are among 2 currently registered trademarks in the portfolio.

What is MONARCH PHARMACEUTICALS, INC.'s trademark registration success rate?

MONARCH PHARMACEUTICALS, INC. has a 13% trademark registration rate, with 2 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.